 hypodens eosinophil interleukin activ blood patient eosinophilia-myalgia syndrom recent recognit eosinophilia-myalgia syndrom em ingest l-tryptophan analysi peripher blood eosinophil phenotyp serum eosinophil disord patient ill abrupt onset skelet muscl edema indur skin blood eosinophilia l-tryptophan ingest eosinophil serum evalu gradient sediment densiti analysi peripher blood eosinophil patient mean sem cell abnorm hypodens phenotyp normodens eosinophil refer donor day medium concentr serum patient em viabil dose-depend manner effect normal serum eosinophil viability-sustain activ mean sem addit anti-interleukin antibodi monospecif granulocyte/macrophag colony-stimul factor gm-csf eosinophilopoiet factor convert peripher blood eosinophil vitro hypodens form extend viabil biolog respons stimuli presenc sera patient em develop mainten eosinophilia convers peripher blood eosinophil hypodens phenotyp augment pathobiolog potenti